CDK-INHIBITOREN

Patent europeic · EP4146647 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4146647
Numer da la dumonda
EP21727336
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
04-05-2021
Publitgà
15-03-2023
Concedì
15-04-2026
La protecziun finescha il pli tard
03-05-2041
Proxima taxa annuala scadenta
31-05-2027
Classas IPC
C07D 471/04 (2006.01)
A61P 35/00 (2006.01)
Prioritad
WO PCT/CN2020/088585 05.05.2020
Dumonda PCT
PCT/US2021/030728 04.05.2021
Publicaziun PCT
WO2021/226140 11.11.2021
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-06-2026

    Midada

    Published in Swissreg on 01.06.2026

  2. 16-04-2026

    Represchentant inscrit

    Representative
    VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 16.04.2026

  3. 15-04-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 15.04.2026

Partidas

Possessur

GENENTECH, INC.

Genentech, Inc.

1 DNA Way, South San Francisco, CA 94080, US

Represchentant

VALIPAT c/o BOVARD LTD

Optingenstrasse 16, 3013 Bern

Inventur

HU, Zhilong

Shanghai, 201314, CN

HE, Hu

Shanghai, 201100, CN

ZHANG, Fei

Shanghai, 201210, CN

ZHONG, Wenge

Thousand Oaks, CA 91362, US

ZHU, Xiaotian

Newton, MA 02465, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.